Not very long ago, Ocugen Inc. (OCGN) stock (previously known as HSGX) was an unpopular biotech stock trading on the NASDAQ that not many investors were aware of. After the merger with Histogenics in 2019, the company made a reverse stock split at the ratio of 1:60. Since then, the […]